Menu
Log in
Log in

News

  • Home
  • Resources
  • Literature Updates
  • Adverse Biology in Adenocarcinoma of the Esophagus and Esophagogastric Junction Impacts Survival and Response to Neoadjuvant Therapy Independent of Anatomic Subtype

Adverse Biology in Adenocarcinoma of the Esophagus and Esophagogastric Junction Impacts Survival and Response to Neoadjuvant Therapy Independent of Anatomic Subtype

22 Oct 2020 10:49 PM | Michele O'Bright (Administrator)

Donlon, Noel E. ; Elliott, Jessie A. ; Donohoe, Claire L. ; Murphy, Conor F. ; Nugent, Tim  Moran, Brendan ; King, Sinead ; Ravi, Narayanasamy ; Reynolds, John V. 

Read the full abstract here...


Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software